Marshall Edwards (MSHL)

0.66 +0.04  +6.43%  May 29, 8:00PM Go Pro
Watch this stock
View Full Chart MSHL Price Chart

Key Stats

Market Cap 9.682M
Revenue Growth
Profit Margin
Earnings Yield -96.97%
Dividend Yield 0.00%
Earnings Per Share TTM -0.64
PE Ratio
Price / Sales Ratio
52 Week High 3.28
52 Week Low 0.54
Beta 2.551
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

News

3:46 AM RT @Bud_Stocks LONG $PGNX and $MSHL and watching $CYCC if it breaks .57 with power Im long there to .63 then reevaluate. posted on the 27th by Bud_Stocks
May 29 Well $CYCC paid off as well as $PGNX but $MSHL is still bleeding by Bud_Stocks
May 29 Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial O...
May 27 @Bud_Stocks $MSHL ..Sounds like a good idea. I did teh same with $EGT. Sold at the top. Waited for a pullback and repurchased. by Urbane_Gorilla
May 27 @Bud_Stocks You're right about the longer term Fibs. I don't like sitting on anything that long. But $MSHL experiences a monthly 20-30% pop by Urbane_Gorilla
May 27 LONG $PGNX and $MSHL and watching $CYCC if it breaks .57 with power Im long there to .63 then reevaluate by Bud_Stocks
May 27 @Bud_Stocks I'll be buying $MSHL on Tuesday.. It'd be nice if it rocketed to 3.00 ..LOL! by Urbane_Gorilla
May 27 @Bud_Stocks Re $MSHL ...I didn't check long term....Just looking for the short term ASCO pop. If it reverses it could easily go to 3.00 by Urbane_Gorilla
May 26 RT @RyanNinz Insider Buys: $KDN 12 $HTCH 10 $HNH 7 $LIME 1m* $HCCI 323* $IGXT 125* Options: $MSHL 4.5m $AMG 50 $MNOV 45 $CALL 24 $BRKR 25 by Bud_Stocks
May 16 New Star Analyst Rankings for Marshall Edwards, Inc.
May 15 MARSHALL EDWARDS INC Files SEC form 10-Q, Quarterly Report
May 14 Marshall Edwards Completes Rights Offering To Stockholders PR Newswire
May 08 Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering Benzinga

Profile

Exchange: NASDAQGM       Sector: Healthcare       Industry: Drug Manufacturers - Other

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Marshall Edwards is down 46.77% over the last year vs S&P 500 Total Return up 2.32%, Allergan up 10.15%, and Tianyin Pharmaceutical down 71.81%.

  • MSHL Total Returns
  • ^SPXTR Total Returns
  • AGN Total Returns
  • TPI Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Income Statement View Statement

Get Quote for

Pro Strategies Featuring MSHL

Did Marshall Edwards make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

MSHL Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
MSHL 0.66 +0.04 +6.43% 9.682M
MSG 37.63 +0.06 +0.16% 2.337B
MSFT 29.32 -0.24 -0.81% 248.03B
MSFG 11.10 -0.06 -0.54% 225.66M
MSF 13.23 -0.21 -1.56%
MSEX 18.14 -0.05 -0.27% 285.58M
MSD 10.77 -0.05 -0.46%
MSCI 34.22 -0.43 -1.24% 4.209B
MSCC 18.00 -0.49 -2.65% 1.617B
MSB 24.80 -0.46 -1.82% 331.41M
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close